Shukra Pharmaceuticals Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹168.85
- Today's High:
- ₹172.2
- Open Price:
- ₹168.85
- 52W Low:
- ₹25.1119
- 52W High:
- ₹194.05
- Prev. Close:
- ₹168.85
- Volume:
- 795
Company Statistics
- Market Cap.:
- ₹214.11 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 678.51%
Company Profile
Shukra Pharmaceuticals Limited had its IPO on under the ticker symbol 524632.
The company operates in the Other sector and Other industry. Shukra Pharmaceuticals Limited has a staff strength of 0 employees.
Stock update
Shares of Shukra Pharmaceuticals Limited opened at ₹168.85 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹168.85 - ₹172.2, and closed at ₹172.2.
This is a +1.98% increase from the previous day's closing price.
A total volume of 795 shares were traded at the close of the day’s session.
In the last one week, shares of Shukra Pharmaceuticals Limited have increased by +15.49%.
Shukra Pharmaceuticals Limited's Key Ratios
Shukra Pharmaceuticals Limited has a market cap of ₹214.11 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Shukra Pharmaceuticals Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Shukra Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Shukra Pharmaceuticals Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 678.51%.
In Q3.6666666666667, Shukra Pharmaceuticals Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Shukra Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shukra Pharmaceuticals Limited’s profitability.
Shukra Pharmaceuticals Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Shukra Pharmaceuticals Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹749.66 million
- Total Liabilities
- ₹425.06 million
- Operating Cash Flow
- ₹-44271000.00
- Capital Expenditure
- ₹44.91 million
- Dividend Payout Ratio
- 0%
Shukra Pharmaceuticals Limited ended 2024 with ₹749.66 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹749.66 million while shareholder equity stood at ₹252.97 million.
Shukra Pharmaceuticals Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹425.06 million in other current liabilities, 39142000.00 in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹39.73 million and cash and short-term investments were ₹39.73 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹37.68 million.
Shukra Pharmaceuticals Limited’s total current assets stands at ₹530.72 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹301.87 million compared to accounts payable of ₹0 and inventory worth ₹31.57 million.
In 2024, Shukra Pharmaceuticals Limited's operating cash flow was ₹-44271000.00 while its capital expenditure stood at ₹44.91 million.
Comparatively, Shukra Pharmaceuticals Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹172.2
- 52-Week High
- ₹194.05
- 52-Week Low
- ₹25.1119
- Analyst Target Price
- ₹
Shukra Pharmaceuticals Limited stock is currently trading at ₹172.2 per share. It touched a 52-week high of ₹194.05 and a 52-week low of ₹194.05. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹145.59 and 200-day moving average was ₹78.49 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.